Reshape Lifesciences Stock Story
RSLS Stock | USD 0.18 0.01 5.26% |
Slightly above 75% of ReShape Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading ReShape Lifesciences stock suggests that many investors are alarmed at this time. ReShape Lifesciences' investor sentiment overview provides quick insight into current market opportunities from investing in ReShape Lifesciences. The current market sentiment, together with ReShape Lifesciences' historical and current headlines, can help investors time the market. In addition, many technical investors use ReShape Lifesciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ReShape Lifesciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ReShape daily returns and investor perception about the current price of ReShape Lifesciences as well as its diversification or hedging effects on your existing portfolios.
ReShape |
Requested story not found. it has been either deleted or moved. View all stories for ReShape Lifesciences.
ReShape Lifesciences Latest Timeline
ReShape Lifesciences is listed for 0.18. The company has price-to-book ratio of 1.38. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ReShape Lifesciences recorded a loss per share of 38.56. The entity last dividend was issued on the 25th of July 2019. The firm had 1:50 split on the 23rd of December 2022.Check out ReShape Lifesciences Hype Analysis, ReShape Lifesciences Correlation and ReShape Lifesciences Performance. For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for ReShape Stock analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (38.56) | Revenue Per Share 4.399 | Quarterly Revenue Growth (0.23) | Return On Assets (0.62) | Return On Equity (2.18) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.